HSCA Statement on House Energy and Commerce Health Subcommittee Hearing on “Made in America: Strengthening Domestic Manufacturing and Our Health Care Supply Chain”
Washington, DC (June 12, 2025) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today released the following statement from President and CEO Angie Boliver regarding the House Energy and Commerce Committee’s recent Health Subcommittee hearing on Made in America: Strengthening Domestic Manufacturing and Our Health Care Supply Chain:
“The Healthcare Supply Chain Association (HSCA), which represents the leading traditional healthcare group purchasing organizations (GPOs), applauds the House Energy and Commerce Committee leadership for their work to enhance domestic manufacturing and resilience in the medical supply chain. As the sourcing and contracting partners to American hospitals and healthcare providers, traditional healthcare GPOs are committed to ensuring that hospitals and the patients they serve have continuous, reliable, and affordable access to medical products. We hope to continue working with bipartisan policymakers to bolster domestic manufacturing.
HSCA supports efforts to increase domestic capacity in the supply chain, and we are proud that our members are able to offer customers the opportunity to source necessary products domestically. GPOs work alongside manufacturers and healthcare providers to increase competition and promote domestic manufacturing, which is vital to ensuring patient access to essential medicines and products. During the COVID-19 pandemic, for example, a number of HSCA member GPOs launched programs to invest in domestic and geographically diverse manufacturers, helping expand production capacity and increase hospital access to critical supplies, including pharmaceuticals. GPOs also help bring new products to market with domestic manufacturers through long-term contracting – a key component designed to support manufacturer investment and sustainability.”
Click here to view the full statement.
Lear MoreHSCA Statement on Recent Executive Order to Promote Domestic Production of Critical Medicines
Washington, DC (May 20, 2025) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today released the following statement from President and CEO Angie Boliver regarding the recent Executive Order on Regulatory Relief to Promote Domestic Production of Critical Medicines:
“HSCA and its traditional healthcare group purchasing organization (GPO) members applaud the Trump Administration’s recent Executive Order on Regulatory Relief to Promote Domestic Production of Critical Medicines. HSCA has long advocated for policymakers to encourage investments in manufacturing capacity and quality, which are of critical importance for hospitals and the patients they serve. We support the Administration’s efforts to align foreign manufacturing facility inspections with those conducted domestically, including by increasing the fees for and number of inspections. Moreover, HSCA supports the order’s provisions focused on streamlining the permitting and construction of domestic manufacturing facilities. Expediting the building process for pharmaceutical manufacturing sites will help suppliers scale up domestic production quickly. We hope to continue working with the Administration on its domestic production objectives moving forward.”
Click here to view the full statement.
Lear MoreHSCA Response to the U.S. Department of Commerce’s Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide comments to the U.S. Department of Commerce on its Section 232 national security investigation into pharmaceutical imports.
Click here to view the full response.
Lear MoreHSCA Response to the U.S. Trade Representative’s Request for Comments on Unfair and Non-Reciprocal Foreign Trade Practices
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide comments to the U.S. Trade Representative (USTR) on ways to strengthen U.S. trade policy and domestic production.
Click here to view the full response.
Lear MoreWhat They’re Saying – Hospitals, Healthcare Organizations, and Patients Supporting the Work of GPOs to Prevent and Mitigate Drug Shortages
Recently, leading healthcare organizations, hospitals, providers, and individuals have made their voices heard on the role traditional healthcare group purchasing organizations (GPOs) play in helping to mitigate and prevent ongoing drug shortages across the country.
Click here to read the full one-pager.
Lear MoreHSCA NAMES ANGIE BOLIVER AS PRESIDENT AND CEO
Washington, D.C. (June 10, 2024) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today announced that it has named GPO industry expert and public affairs veteran Angie Boliver as President and Chief Executive Officer (CEO). The announcement follows the retirement of former President and CEO Todd Ebert, who led HSCA for seven years.
Click here to read the full press release.
Lear MoreHSCA Comments on Federal Trade Commission (FTC) and Department of Health and Human Services (HHS) Joint RFI on Generic Drug Shortages
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide our response to the joint RFI published by the FTC and HHS on February 15, 2024.
Click here to read the full response.
Lear More